Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Epigenetic drug discovery: a success story for cofactor interference
by
Ganesan, A.
in
Arginine
/ Cations
/ Clinical trials
/ Coenzyme A
/ Cofactors
/ Deoxyribonucleic acid
/ DNA
/ Drug development
/ Enzyme Inhibitors
/ Enzymes
/ Epigenetics
/ Flavin-adenine dinucleotide
/ Lysine
/ Medical research
/ NAD
/ Nicotinamide
/ Nicotinamide adenine dinucleotide
/ Regulatory approval
/ Review
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Epigenetic drug discovery: a success story for cofactor interference
by
Ganesan, A.
in
Arginine
/ Cations
/ Clinical trials
/ Coenzyme A
/ Cofactors
/ Deoxyribonucleic acid
/ DNA
/ Drug development
/ Enzyme Inhibitors
/ Enzymes
/ Epigenetics
/ Flavin-adenine dinucleotide
/ Lysine
/ Medical research
/ NAD
/ Nicotinamide
/ Nicotinamide adenine dinucleotide
/ Regulatory approval
/ Review
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Epigenetic drug discovery: a success story for cofactor interference
by
Ganesan, A.
in
Arginine
/ Cations
/ Clinical trials
/ Coenzyme A
/ Cofactors
/ Deoxyribonucleic acid
/ DNA
/ Drug development
/ Enzyme Inhibitors
/ Enzymes
/ Epigenetics
/ Flavin-adenine dinucleotide
/ Lysine
/ Medical research
/ NAD
/ Nicotinamide
/ Nicotinamide adenine dinucleotide
/ Regulatory approval
/ Review
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Epigenetic drug discovery: a success story for cofactor interference
Journal Article
Epigenetic drug discovery: a success story for cofactor interference
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Within the past two decades, seven epigenetic drugs have received regulatory approval and numerous other candidates are currently in clinical trials. Among the epigenetic targets are the writer and eraser enzymes that are, respectively, responsible for the reversible introduction and removal of structural modifications in the nucleosome. This review discusses the progress achieved in the design and development of inhibitors against the key writer and eraser pairs: DNA methyltransferases and Tet demethylases; lysine/arginine methyltransferases and lysine demethylases; and histone acetyltransferases and histone deacetylases. A common theme for the successful inhibition of these enzymes in a potent and selective manner is the targeting of the cofactors present in the active site, namely zinc and iron cations, S-adenosylmethione, nicotinamide adenine dinucleotide, flavin adenine dinucleotide and acetyl Coenzyme A.
This article is part of a discussion meeting issue ‘Frontiers in epigenetic chemical biology’.
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.